DMAAU
Drugs Made In America Acquisition
$10.99
+$0.27 (+2.52%)Jul 27, 2026
Key metrics
The numbers that frame DMAAU today
- 52wk Low
- $10.30
- 52wk High
- $12.50
Growth
Revenue and earnings trend for DMAAU
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DMAAU
Is Drugs Made In America Acquisition a good buy?
Yes. Drugs Made In America Acquisition has strong momentum.
What is the 52-week high for DMAAU stock?
The 52-week high for Drugs Made In America Acquisition is $12.50. The current close of $10.99 is 12.1% below that high.
What is the 52-week low for DMAAU stock?
The 52-week low for Drugs Made In America Acquisition is $10.30. The current close of $10.99 is 6.7% above that low.